EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.5600
-0.0100 (-1.75%)
Jun 5, 2026, 4:10 PM AEST
EZZ Life Science Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 61.4 | 66.87 | 66.44 | 37.14 | 15.02 | 22.29 |
| 61.4 | 66.87 | 66.44 | 37.14 | 15.02 | 22.29 | |
Revenue Growth (YoY) | -18.17% | 0.65% | 78.88% | 147.26% | -32.60% | 24.03% |
Cost of Revenue | 16.78 | 17.15 | 15.5 | 8.61 | 7.51 | 9.83 |
Gross Profit | 44.62 | 49.72 | 50.95 | 28.53 | 7.51 | 12.46 |
Selling, General & Admin | 33.13 | 35.87 | 38.49 | 21.7 | 4.14 | 8.68 |
Other Operating Expenses | 4.85 | 3.41 | 2.35 | 2.03 | 1.46 | 0.9 |
Operating Expenses | 39.36 | 39.79 | 41.23 | 23.91 | 5.72 | 9.71 |
Operating Income | 5.26 | 9.93 | 9.72 | 4.62 | 1.78 | 2.75 |
Interest Expense | -0.03 | -0.03 | -0.02 | -0.01 | -0 | -0.01 |
Interest & Investment Income | 0.39 | 0.42 | 0.2 | 0.04 | 0 | - |
Currency Exchange Gain (Loss) | 0.24 | 0.24 | 0.07 | 0.22 | - | - |
Other Non Operating Income (Expenses) | 0.03 | 0.03 | - | 0.04 | - | - |
Pretax Income | 5.88 | 10.59 | 9.96 | 4.9 | 1.78 | 2.74 |
Income Tax Expense | 2.99 | 3.86 | 2.99 | 1.27 | 0.47 | 0.71 |
Net Income | 2.89 | 6.73 | 6.96 | 3.63 | 1.31 | 2.03 |
Net Income to Common | 2.89 | 6.73 | 6.96 | 3.63 | 1.31 | 2.03 |
Net Income Growth | -67.94% | -3.36% | 91.87% | 176.57% | -35.37% | 28.02% |
Shares Outstanding (Basic) | 47 | 46 | 43 | 43 | 43 | 34 |
Shares Outstanding (Diluted) | 47 | 46 | 43 | 43 | 43 | 34 |
Shares Change (YoY) | 6.22% | 7.35% | 0.89% | 0.46% | 25.23% | 13.15% |
EPS (Basic) | 0.06 | 0.15 | 0.16 | 0.08 | 0.03 | 0.06 |
EPS (Diluted) | 0.06 | 0.15 | 0.16 | 0.08 | 0.03 | 0.06 |
EPS Growth | -69.81% | -9.99% | 90.19% | 175.31% | -48.37% | 13.10% |
Free Cash Flow | -2.69 | 4.13 | 5.73 | 3.91 | 1.9 | 0.25 |
Free Cash Flow Per Share | -0.06 | 0.09 | 0.13 | 0.09 | 0.04 | 0.01 |
Dividend Per Share | 0.020 | 0.040 | 0.035 | 0.020 | 0.004 | 0.004 |
Dividend Growth | -50.00% | 14.29% | 76.77% | 340.00% | - | - |
Gross Margin | 72.67% | 74.35% | 76.68% | 76.81% | 49.98% | 55.90% |
Operating Margin | 8.56% | 14.85% | 14.62% | 12.43% | 11.88% | 12.33% |
Profit Margin | 4.71% | 10.06% | 10.48% | 9.77% | 8.74% | 9.11% |
Free Cash Flow Margin | -4.38% | 6.17% | 8.63% | 10.53% | 12.62% | 1.11% |
EBITDA | 5.42 | 10.08 | 9.75 | 4.63 | 1.8 | 2.76 |
EBITDA Margin | 8.82% | 15.08% | 14.68% | 12.48% | 11.98% | 12.41% |
D&A For EBITDA | 0.16 | 0.15 | 0.03 | 0.02 | 0.02 | 0.02 |
EBIT | 5.26 | 9.93 | 9.72 | 4.62 | 1.78 | 2.75 |
EBIT Margin | 8.56% | 14.85% | 14.62% | 12.43% | 11.88% | 12.33% |
Effective Tax Rate | 50.86% | 36.42% | 30.07% | 25.93% | 26.26% | 25.80% |
Advertising Expenses | - | 32.27 | 37.23 | 20.56 | 2.97 | 7.84 |